Our longitudinal analysis showed that in the subgroup of critically ill COVID‐19 patients who tested positive for auto‐Abs neutralizing IFN‐α subtypes and IFN‐ω, the persistence of high NAB titers was correlated with lack of expression of ISGs after a median time of 15 days from the start of their hospital admission. The gene discussed is IFNA1; the disease is COVID-19.